COSMOS Pharmaceutical Corporation

TSE:3349.T

7358 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 24,45432,77333,04838,59630,40227,13925,16725,73720,49619,42018,41616,65214,39810,5698,7555,3264,1314,3213,7192,402
Depreciation & Amortization 19,92417,36815,11013,78513,56212,95811,88510,7109,5887,3425,6044,2473,1042,3621,8571,4221,025844634418
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital 9,66610,164-1,203-10,93425,7762553,5347,3297,9931248,8704,4663,6005,294-1615,0744,626-325-2482,002
Accounts Receivables -1,829-254-978289-306-1,276-326-241-84200000000
Inventory -8,704-11,156-5,853-7,006-295-4,725-8,710-1,824-3,604-3,602-3,727-3,333-4,549-350-2,865-1,680-1,370-1,697-3,573-2,610
Accounts Payables 17,69722,6276,183-3,49125,7365,73413,3269,26311,69900000000000
Other Working Capital 2,502-1,053-1,436-44546-44812,2449,15311,5973,72612,5977,7998,1495,6442,7046,7545,9961,3723,3254,612
Other Non Cash Items 33,815-5,871-14,761-13,572-4,279-5,973-8,000-6,838-7,091-7,432-6,928-6,600-5,007-4,059-2,717-1,739-2,088-2,033-807-1,317
Operating Cash Flow 55,17554,43432,19427,87565,46134,37932,58636,93830,98619,45425,96218,76516,09514,1667,73410,0837,6942,8073,2983,505
Investing Activities:
Investments In Property Plant And Equipment -55,810-46,636-43,497-26,064-25,948-29,040-29,451-28,667-31,092-29,865-20,144-18,030-11,138-6,680-3,659-5,193-3,987-7,151-3,030-2,804
Acquisitions Net 718461,5198,677-18441243328514582455000000000
Purchases Of Investments -523-500-713-597-214-398-576-1,104-1,19800000000000
Sales Maturities Of Investments 43142840741739840040086660400000000000
Other Investing Activites -2,143-2,451-1,433-1,814-1,008-1,416-1,050-652,02811-429-602-509-1,181-846-884-1,215-432-1,389-729
Investing Cash Flow -57,329-49,113-43,717-19,381-26,956-30,042-30,458-28,404-28,550-29,272-20,118-18,632-11,647-7,861-4,505-6,077-5,202-7,583-4,419-3,533
Financing Activities:
Debt Repayment -13,187-1,628-1,486-1,486-1,486-3,199-4,486-4,951-5,006-2,515-1,486-1,734-2,246-2,983-2,739-3,007-2,842-2,451-2,011-2,551
Common Stock Issued 08,144-1,46600000002,125000004,00005,5782,790
Common Stock Repurchased 0-2-20000000-100000-2330-414,046
Dividends Paid -4,659-3,266-3,266-2,277-2,077-1,781-1,781-1,385-1,237-1,138-1,088-831-1,049-455-297-197-199-199-134-37
Other Financing Activities -1-3-2-1,744-1,842-2,002-1,921-1,75212,45410,804-2-758-576-4231,6873,354-35,078-2-1
Financing Cash Flow 8,5273,245-6,222-5,507-5,405-6,982-8,188-8,0886,2117,151-452-3,323-3,871-3,861-1,3491507232,4283,3904,247
Other Information:
Effect Of Forex Changes On Cash 00-1-10-10000-100-1000010
Net Change In Cash 6,3738,566-17,7462,98633,100-2,646-6,0604468,647-2,6675,391-3,1905772,4431,8804,1563,215-2,3482,2704,219
Cash At End Of Period 52,30145,92837,36255,10852,12219,02221,66827,72827,28218,63521,30215,91119,10118,52416,08114,20110,0456,8309,1786,908